This is a Validated Antibody Database (VAD) review about mouse Fgfr3, based on 4 published articles (read how Labome selects the articles), using Fgfr3 antibody in all methods. It is aimed to help Labome visitors find the most suited Fgfr3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Fgfr3 synonym: CD333; FR3; Fgfr-3; Flg-2; HBGFR; Mfr3; sam3

Abcam
domestic rabbit monoclonal (EPR2304(3))
  • western blot; human; 1:500; loading ...; fig 2k
Abcam Fgfr3 antibody (Abcam, ab133644) was used in western blot on human samples at 1:500 (fig 2k). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (EPR2281(3))
  • western blot; human; loading ...; fig 4b
Abcam Fgfr3 antibody (Abcam, ab155960) was used in western blot on human samples (fig 4b). J Exp Clin Cancer Res (2019) ncbi
Santa Cruz Biotechnology
mouse monoclonal (E-7)
  • immunohistochemistry - frozen section; human; 1:50; loading ...; fig s7b
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 5a
Santa Cruz Biotechnology Fgfr3 antibody (Santa Cruz, sc-390423) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig s7b) and in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 5a). Nat Commun (2021) ncbi
R&D Systems
rat monoclonal (136812)
  • blocking or activating experiments; mouse; loading ...; tbl 1
R&D Systems Fgfr3 antibody (R&D Systems, MAB710) was used in blocking or activating experiments on mouse samples (tbl 1). Front Cell Dev Biol (2021) ncbi
Articles Reviewed
  1. Washausen S, Knabe W. Responses of Epibranchial Placodes to Disruptions of the FGF and BMP Signaling Pathways in Embryonic Mice. Front Cell Dev Biol. 2021;9:712522 pubmed publisher
  2. Guo T, Gu C, Li B, Xu C. Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain. Aging (Albany NY). 2021;13:19750-19759 pubmed publisher
  3. Zhang D, Huang J, Sun X, Chen H, Huang S, Yang J, et al. Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway. Nat Commun. 2021;12:4391 pubmed publisher
  4. Si J, Ma Y, Bi J, Xiong Y, Lv C, Li S, et al. Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties. J Exp Clin Cancer Res. 2019;38:481 pubmed publisher